The Data Catalog Paradox: Why the Front Office Needs a Different Kind of Data Discovery

In a 2025 Bloomberg survey of over 150 quants, research analysts, and data scientists across capital markets, one bottleneck stood out: 72% could evaluate only three or fewer datasets at a time, and for 65%, evaluating even a single dataset takes a month or longer. In a market where alpha increasingly depends on who can ingest and act on new data fastest, most teams are stuck in a months-long queue before the real analysis even starts.

The mechanics of that queue are painfully familiar. When a quant needs to evaluate a new alternative dataset for a factor model, the journey typically starts with a message to the data engineering team, followed by days of back-and-forth to understand what the dataset contains, how it was sourced, whether the quality is reliable, and whether the firm is licensed to use it for that purpose. By the time the data reaches the analyst's notebook, the trading signal may already be stale. Worse, the institutional knowledge generated through that entire evaluation — what worked, what didn't, which fields were unreliable, which vendor was unresponsive — all of it lives in email threads and the heads of the people involved, never making it back into any system the next analyst can search. 

The irony is that most of these firms have invested heavily in data infrastructure. They have technical data catalogs. They have cloud platforms. They have data lakes measured in petabytes. The problem is not the absence of data. It is the absence of data discovery built for the people who actually need to use it.

The Catalog Gap: Built for Pipelines, Not Portfolios

Technical data catalogs were designed primarily for data engineering teams. They excel at schema documentation, pipeline lineage tracking, and technical metadata. These are valuable capabilities. But they solve a different problem from the one facing the front office.

A portfolio manager evaluating whether to add satellite imagery data to a macro strategy does not need column-level metadata. They need to know: What does this dataset actually measure? How frequently is it updated? What is the data quality like in practice? Has anyone else at the firm used it, and for what? What are the licensing restrictions? Can I use it in a systematic strategy, or only for discretionary research? 

Capital markets data carries context that generic business data catalogs were never designed to capture. A single dataset may have different licensing terms for proprietary trading versus client research versus index construction, embargo periods that vary by desk, and quality dimensions — survivorship bias, point-in-time correctness, coverage universe — that determine whether the data is usable before anyone looks at a single row.

The commercial impact is quantifiable, and it falls in two places. Data leaders running these environments know the numbers. Global financial data spend reached $49.2 billion in 2025 (Burton-Taylor). Yet meaningful, active utilisation of licensed datasets rarely exceeds 30%. And for the front office, it compounds: longer evaluation cycles mean slower research, and slower research means the analysis arrives after the opportunity has moved. Both pressures land on the same bottom line.

The consequences compound across the organisation: